Head and neck dermatitis: a variant of atopic dermatitis

被引:0
作者
Blicharz, Leszek [1 ]
Michalczyk, Agnieszka [1 ]
Maj, Malgorzata [1 ]
Czuwara, Joanna [1 ]
Olszewska, Malgorzata [1 ]
Rudnicka, Lidia [1 ]
机构
[1] Med Univ Warsaw, Dept Dermatol, Koszykowa 82A, PL-02008 Warsaw, Poland
关键词
Allergy; Dermatitis; atopic; Biological products; Malassezia; Janus kinase inhibitors; MOLLUSCUM CONTAGIOSUM; ECZEMA COXSACKIUM; ALOPECIA-AREATA; CONTACT-DERMATITIS; VIRAL-INFECTIONS; DOUBLE-BLIND; MALASSEZIA; DIAGNOSIS; SKIN; DUPILUMAB;
D O I
10.23736/S2784-8671.25.08001-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Atopic dermatitis involves the head and neck area across all age groups. This manifestation is frequently referred to as "the head and neck dermatitis." Aside from a considerable deterioration of the quality of life, it poses a significant diagnostic and therapeutic challenge. The head and neck dermatitis may be mimicked by other inflammatory conditions such as seborrheic dermatitis or contact dermatitis. Furthermore, it can be associated with a wide range of infectious, ocular, psychiatric and hair disorders, which should raise clinical alertness and encourage a multidisciplinary management of the affected individuals. Skin lesions in the head and neck area are often difficult to treat, particularly because of a considerable exposure of this region to exacerbating factors and limitations regarding the use of some pharmaceuticals. Although several hypotheses explaining the recalcitrant course of head and neck dermatitis have been proposed, none of them provide successful solutions applicable in the daily clinical practice. This comprehensive review comprises the current insights on the pathogenesis, clinical presentation, and comorbidities of the head and neck dermatitis. Recommendations regarding possible treatments of this condition such as antifungals, as well as special considerations for the choice of biologics or JAK inhibitors in the candidates for systemic treatment are outlined.
引用
收藏
页码:123 / 144
页数:22
相关论文
共 212 条
[41]  
Elboukhari K, 2020, J Dermatol Res, V01
[42]  
Elghblawi Ebtisam, 2017, Int J Trichology, V9, P47, DOI 10.4103/ijt.ijt_54_16
[43]   Histopathologic Features of Maculopapular Drug Eruption [J].
Ernst, Madison ;
Giubellino, Alessio .
DERMATOPATHOLOGY, 2022, 9 (02) :111-121
[44]   Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): An Up-to-Date Overview [J].
Errichetti, Enzo .
DERMATOLOGY PRACTICAL & CONCEPTUAL, 2019, 9 (03) :169-180
[45]   The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment [J].
Facheris, Paola ;
Jeffery, Jane ;
Del Duca, Ester ;
Guttman-Yassky, Emma .
CELLULAR & MOLECULAR IMMUNOLOGY, 2023, 20 (05) :448-474
[46]  
Fadadu Raj P, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20032526
[47]  
Farshchian M., 2024, Rosacea
[48]   Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review [J].
Fasseeh, Ahmad N. ;
Elezbawy, Baher ;
Korra, Nada ;
Tannira, Mohamed ;
Dalle, Hala ;
Aderian, Sandrine ;
Abaza, Sherif ;
Kalo, Zoltan .
DERMATOLOGY AND THERAPY, 2022, 12 (12) :2653-2668
[49]  
Federico JR, 2024, Angular Chelitis
[50]   Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age [J].
Flohr, C. ;
England, K. ;
Radulovic, S. ;
McLean, W. H. I. ;
Campbell, L. E. ;
Barker, J. ;
Perkin, M. ;
Lack, G. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (06) :1333-1336